417 related articles for article (PubMed ID: 23022474)
1. Cancer genetics and genomics of human FOX family genes.
Katoh M; Igarashi M; Fukuda H; Nakagama H; Katoh M
Cancer Lett; 2013 Jan; 328(2):198-206. PubMed ID: 23022474
[TBL] [Abstract][Full Text] [Related]
2. Human FOX gene family (Review).
Katoh M; Katoh M
Int J Oncol; 2004 Nov; 25(5):1495-500. PubMed ID: 15492844
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review).
Katoh Y; Katoh M
Int J Mol Med; 2008 Sep; 22(3):271-5. PubMed ID: 18698484
[TBL] [Abstract][Full Text] [Related]
4. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.
Santo EE; Ebus ME; Koster J; Schulte JH; Lakeman A; van Sluis P; Vermeulen J; Gisselsson D; Øra I; Lindner S; Buckley PG; Stallings RL; Vandesompele J; Eggert A; Caron HN; Versteeg R; Molenaar JJ
Oncogene; 2012 Mar; 31(12):1571-81. PubMed ID: 21860421
[TBL] [Abstract][Full Text] [Related]
6. Germ-line mutation of Foxn5 gene in mouse lineage.
Katoh M; Katoh M
Int J Mol Med; 2004 Sep; 14(3):463-7. PubMed ID: 15289901
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of WNT2B based on the balance of Hedgehog, Notch, BMP and WNT signals.
Katoh M; Katoh M
Int J Oncol; 2009 May; 34(5):1411-5. PubMed ID: 19360354
[TBL] [Abstract][Full Text] [Related]
9. Deregulated FOX genes in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Genes Chromosomes Cancer; 2014 Nov; 53(11):917-33. PubMed ID: 25043849
[TBL] [Abstract][Full Text] [Related]
10. FGF receptors: cancer biology and therapeutics.
Katoh M; Nakagama H
Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of human FOXN6, mouse Foxn6, and rat Foxn6 genes in silico.
Katoh M; Katoh M
Int J Oncol; 2004 Jul; 25(1):219-23. PubMed ID: 15202009
[TBL] [Abstract][Full Text] [Related]
12. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.
Banham AH; Beasley N; Campo E; Fernandez PL; Fidler C; Gatter K; Jones M; Mason DY; Prime JE; Trougouboff P; Wood K; Cordell JL
Cancer Res; 2001 Dec; 61(24):8820-9. PubMed ID: 11751404
[TBL] [Abstract][Full Text] [Related]
13. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
14. The involvement of oncogenes and suppressor genes in human neoplasia.
Brodeur GM
Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
[TBL] [Abstract][Full Text] [Related]
15. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A
Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of human FOXN5 and rat Foxn5 genes in silico.
Katoh M; Katoh M
Int J Oncol; 2004 May; 24(5):1339-44. PubMed ID: 15067358
[TBL] [Abstract][Full Text] [Related]
17. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
18. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
19. The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer.
Reagan-Shaw S; Ahmad N
Toxicol Appl Pharmacol; 2007 Nov; 224(3):360-8. PubMed ID: 17275054
[TBL] [Abstract][Full Text] [Related]
20. FOXP1: a potential therapeutic target in cancer.
Koon HB; Ippolito GC; Banham AH; Tucker PW
Expert Opin Ther Targets; 2007 Jul; 11(7):955-65. PubMed ID: 17614763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
